Literature DB >> 19474653

Rhabdomyolysis following clarithromycin monotherapy.

Zachary Z Brener1, Ilya Bilik, Boris Khorets, James F Winchester, Michael Bergman.   

Abstract

Macrolide antibiotics inhibit the metabolism of hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) that may result in myopathy and rhabdomyolysis. We report the first case of rhabdomyolysis related to the administration of clarithromycin without concurrent use of other medications. Inhibition of cytochrome P450 could be one of the potential causative mechanisms of myopathy in our case. Clinicians should be aware of this potential adverse effect of a widely used drug.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474653     DOI: 10.1097/MAJ.0b013e31819e221f

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.

Authors:  Matthew W Carroll; Hongjo Choi; Seonyeong Min; Soohee Hwang; Hyeeun Park; Taeksun Song; Yumi Park; Han-Seung Jeon; Lisa C Goldfeder; Laura E Via; Janette Lebron; Boyoung Jin; Ying Cai; Clifton E Barry; Myungsun Lee
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

2.  Life-threatening rhabdomyolysis following the interaction of two commonly prescribed medications.

Authors:  Alireza Fallah; Maitri Deep; David Smallwood; Peter Hughes
Journal:  Australas Med J       Date:  2013-03-31

3.  Rhabdomyolysis following a short course of clarythromycin.

Authors:  Anna M Schor; Ann Hellerstein
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

4.  Clarithromycin-induced rhabdomyolysis: a case report.

Authors:  Giuseppe Pasqualetti; Giacomo Bini; Sara Tognini; Antonio Polini; Fabio Monzani
Journal:  Int J Gen Med       Date:  2012-03-20

Review 5.  Potential factors involved in the causation of rhabdomyolysis following status asthmaticus.

Authors:  Hongmei Qiao; Huanji Cheng; Li Liu; Jianing Yin
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-22       Impact factor: 3.406

Review 6.  Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes.

Authors:  Enas A Enas; Arun Kuruvila; Pravien Khanna; C S Pitchumoni; Viswanathan Mohan
Journal:  Indian J Med Res       Date:  2013-10       Impact factor: 2.375

7.  Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Chengwen Teng; Courtney Baus; James P Wilson; Christopher R Frei
Journal:  Int J Med Sci       Date:  2019-10-15       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.